ARCHIVES

FDA, NCI Seek Compromise On Survival Endpoints

This article is from The Cancer Letter archive.

Vol. 15 No. 24 | June 16, 1989

Download PDF Visit The Full Archive

Related Articles

Ovarian Cancer Screening Unnecessary for Most Women, Consensus Panel Says

April 15, 1994

NCI Programs: Institute To Expand Career Development, Training Grants

December 18, 1998

Q&A With The Cancer Letter: MD Anderson Provost Had No Say

May 25, 2012

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

February 21, 2003

Perot Systems To Provide IT Support For US Oncology Enterprise Applications.

December 15, 2000

FDA Spells Out Requirement For INDs For Cancer Drugs.

May 17, 2002